INVO Bioscience Inc (INVO)
0.89
+0.02
(+2.29%)
USD |
NASDAQ |
May 24, 16:00
0.88
-0.01
(-1.12%)
After-Hours: 20:00
INVO Bioscience Gross Profit (Quarterly): 0.7261M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.7261M |
| December 31, 2023 | 0.495M |
| September 30, 2023 | 0.3939M |
| June 30, 2023 | 0.0605M |
| March 31, 2023 | 0.117M |
| December 31, 2022 | 0.0436M |
| September 30, 2022 | -0.0137M |
| June 30, 2022 | -0.0465M |
| March 31, 2022 | 0.0976M |
| December 31, 2021 | 3.001M |
| September 30, 2021 | 0.1985M |
| June 30, 2021 | 0.1939M |
| March 31, 2021 | 0.6218M |
| December 31, 2020 | 0.1864M |
| September 30, 2020 | 0.3087M |
| June 30, 2020 | 0.2249M |
| March 31, 2020 | 0.2286M |
| December 31, 2019 | 0.3001M |
| September 30, 2019 | 0.2586M |
| June 30, 2019 | 0.6034M |
| March 31, 2019 | 0.1785M |
| December 31, 2018 | 0.1111M |
| September 30, 2018 | 0.1097M |
| June 30, 2018 | 0.0935M |
| March 31, 2018 | 0.0897M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.0703M |
| September 30, 2017 | 0.0554M |
| June 30, 2017 | 0.0661M |
| March 31, 2017 | 0.0384M |
| December 31, 2016 | 0.0064M |
| September 30, 2016 | 0.0114M |
| June 30, 2016 | 0.0031M |
| March 31, 2016 | 0.0149M |
| December 31, 2015 | -0.0017M |
| September 30, 2015 | -0.0019M |
| June 30, 2015 | 0.006M |
| March 31, 2015 | 0.0014M |
| December 31, 2011 | 0.0017M |
| September 30, 2011 | 0.0096M |
| June 30, 2011 | 0.0154M |
| March 31, 2011 | 0.0268M |
| December 31, 2010 | 0.0214M |
| September 30, 2010 | -0.0017M |
| June 30, 2010 | 0.0076M |
| March 31, 2010 | 0.0185M |
| December 31, 2009 | -0.004M |
| September 30, 2009 | -0.0008M |
| June 30, 2009 | 0.0105M |
| March 31, 2009 | 0.0161M |
| December 31, 2008 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-0.0465M
Minimum
Jun 2022
3.001M
Maximum
Dec 2021
0.40M
Average
0.2267M
Median
Gross Profit (Quarterly) Benchmarks
| Abbott Laboratories | 5.501B |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 17.30M |
| Asensus Surgical Inc | -1.933M |
| Catheter Precision Inc | 0.077M |